Research Article
Evaluation of Brain SPECT with 99mTc-TRODAT-1 in the Differential Diagnosis of Parkinsonism
Table 2
Correlations of the brain SPECT with 99mTc-TRODAT-1 of the groups with Parkinsonism.
| Variables | Synucleinopathies (SNP) | (SNP) | (PD × MSA) | (PD × LBD) | Tauopathies (TP) | (TP) | (TP × SNP) | (TP × PD) | DIP (19) | (DIP × SNP) | (DOP × PD) | VP (13) | (VP × SNP) | (VP × PD) | PD (93) | MSA (7) | LBD (16) | PSP (2) | CBD (3) |
| Regarding normality (%) | 93 (100%) | 7 (100%) | 16 (100%) | 1 | | | 2 (100%) | 3 (100%) | 1 | 1 | 1 | 11 (57.9%) | <0.0001 | <0.0001 | 10 (77.0%) | <0.0001 | 0.0001 | Abnormal exam | | | | | | | | | | | | | | | | | | Severity of the alterations | Normal or zero | 0 (0%) | 0 (0%) | 0 (0%) | 0.199 | 0.209 | 0.814 | 0 (0%) | 0 (0%) | 0.764 | 0.685 | 0.863 | 8 (42.1%) | <0.0001 | <0.0001 | 3 (23.1%) | <0.0001 | <0.0001 | Mild reduction or 1 | 1 (1.1%) | 1 (14.3%) | 0 (0%) | | | | 0 (0%) | 0 (0%) | | | | 4 (21.1%) | | | 2 (15.4%) | | | Moderate reduction or 2 | 19 (20.4%) | 1 (14.3%) | 3 (18.7%) | | | | 1 (50%) | 1 (33.3%) | | | | 7 (36.8%) | | | 3 (23.1%) | | | Accentuate reduction or 3 | 56 (60.2%) | 4 (57.1%) | 8 (50%) | | | | 0 (0%) | 2 (66.7%) | | | | 0 (0%) | | | 5 (38.5%) | | | Severe reduction or 4 | 17 (18.3%) | 1 (14.3%) | 5 (31.3%) | | | | 1 (50%) | 0 (0%) | | | | 0 (0%) | | | 0 (0%) | | | Symmetry of the abnormal (%) | Asymmetric | 77 (82.6%) | 6 (85.7%) | 13 (81.3%) | 0.999 | 1 | 0.999 | 1 (50%) | 3 (100%) | 0.400 | 0.974 | 0.713 | 8 (42.1%) | <0.0001 | <0.0001 | 6 (46.2%) | <0.0001 | <0.0001 | Symmetric | 16 (17.2%) | 1 (14.3%) | 3 (18.7%) | | | | 1 (50%) | 0 (0%) | | | | 3 (15.8%) | | | 4 (30.8%) | | | Normal | 0 (0%) | 0 (0%) | 0 (0%) | | | | 0 (0%) | 0 (0%) | | | | 8 (42.1%) | | | 3 (23.1%) | | | Laterality symptoms | Unilateral | 89 (95.7%) | 6 (85.71%) | 13 (81.25%) | 0.051 | 0.309 | 0.063 | 1 (50%) | 3 (100%) | 0.400 | 0.036 | 0.105 | 14 (73.78%) | 0.028 | 0.006 | 8 (61.53%) | 0.002 | 0.001 | Left | 35 (37.6%) | 1 (14.3%) | 8 (50%) | | | | 0 (0%) | 2 (66.7%) | | | | 5 (26.3%) | | | 2 (15.4%) | | | Right | 54 (58.1%) | 5 (71.4%) | 5 (31.3%) | | | | 1 (50%) | 1 (33.3%) | | | | 9 (47.4%) | | | 6 (46.2%) | | | Undefined—bilateral | 4 (4.3%) | 1 (14.3%) | 3 (18.8%) | | | | 1 (50%) | 0 (0%) | | | | 5 (26.3%) | | | 5 (38.5%) | | | Laterality-SPECT-TRODAT | Unilateral | 76 (81.72%) | 6 (87.71%) | 13 (81.25%) | 0.999 | 1 | 1 | 1 (50%) | 3 (100%) | 0.400 | 0.394 | 0.717 | 11 (57.9%) | 0.227 | 0.033 | 6 (46.2%) | 0.065 | 0.009 | Left | 43 (46.2%) | 3 (42.9%) | 7 (43.8%) | | | | 1 (50%) | 0 (0%) | | | | 8 (42.1%) | | | 5 (38.5%) | | | Right | 33 (35.5%) | 3 (42.9%) | 6 (37.5%) | | | | 0 (0%) | 3 (100%) | | | | 3 (15.8%) | | | 1 (7.7%) | | | Undefined—bilateral | 17 (18.3%) | 1 (14.3%) | 3 (18.8%) | | | | 1 (50%) | 0 (0%) | | | | 8 (42.1%) | | | 7 (53.8%) | | | Laterality corresponding to the most affected side (%) | Yes | 68 (73.18) | 5 (71.42) | 11 (68.75) | 0.689 (sim × não) 0.041 (bilat × contra) | 1 (sim × não) 0.306 (bilat × contra) | 0.508 (sim × não) 0.052 (bilat × contra) | 2 (100%) | 2 (66.6%) | 1 (sim × não) 1 (bilat × contra) | 0.807 (sim × não) 0.059 (bilat × contra) | 0.938 (sim × não) 0.254 (bilat × contra) | 17 (89.5%) (89.47%) | 0.566 (sim × não) <0.0001 (bilat × contra) | 1 (sim × não) <0.0001 (bilat × contra) | 11 (84.6%) (84.61%) | 0.824 (sim × não) <0.0001 (bilat × contra) | 0.508 (sim × não) <0.0001 (bilat × contra) | Contralateral | 64 (69%) | 4 (57.1%) | 8 (50%) | | | | 1 (50%) | 2 (66.66%) | | | | 6 (31.6%) | | | 4 (30.86%) | | | Bilateral | 4 (4.3%) | 1 (14.3%) | 3 (18.75%) | | | | 1 (50%) | 0 0%) | | | | 11 (58%) | | | 7 (53.8%) | | | No | 25 (26.9%) | 2 (28.6%) | 2 (12.5%) | | | | 0 (0%) | 1 (33%) | | | | 2 (10.5%) | | | 2 | | | Ipsilateral | 9 (9.7%) | 1 (14.3%) | 2 (12.5%) | | | | 0 (0%) | 1 (33.33%) | | | | 1 (5.26%) | | | 0 (0%) | | | Undefined | 16 (17.2%) | 1 (14.3%) | 0 | | | | 0 (0%) | 0 (0%) | | | | 1 (5.26%) | | | 2 (15.4%) | | |
|
|
PD: Parkinson’s disease, MSA: multiple system atrophy, LBD: Lewy body dementia, SNP: synucleinopathies, TP: tauopathies, PSP: progressive supranuclear palsy, CBD: cortico-basal degeneration, DIP: drug-induced Parkinsonism, VP: vascular Parkinsonism, RLS: restless legs syndrome, RSBD: REM sleep behavioral disorder, DRSBD: duration of REM sleep disorder. ∗p<0.05 indicated statistical significance. |